Evading immune responses evoked by proinsulin antigens by deleting insulin genes has been shown to prevent diabetes in the NOD mouse, emphasizing the importance of this T cell subset as a potential therapeutic target [6, 8]. The gene discussed is INS; the disease is diabetes mellitus.